Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05645055

Biologics for Stricturing Crohn's Diseases

Conditions: The Efficacy of Biologics for Stricturing Crohn's Diseases

Sex: All
Ages: 16 Years – 65 Years
Enrollment: 200
Sponsor: Jinling Hospital, China

Location: China

Summary

Recents researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.

Eligibility Criteria

Inclusion Criteria:patients with stricturing Crohn's diseasesno surgical indicationpatients with asymptomatic penetrating diseaseswritten consent acquiredExclusion Criteria:patients with surgical indicationpatients with sympotomatic penetrating diseasescontraindication of biologicsanticipating other trial

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05645055). StuddyBuddy aggregates publicly available trial information.